Provided by Tiger Trade Technology Pte. Ltd.

Autonomix Medical Inc

4.81
-0.5100-9.59%
Volume:189.61K
Turnover:917.07K
Market Cap:4.67M
PE:-0.10
High:5.20
Open:5.20
Low:4.71
Close:5.32
52wk High:32.55
52wk Low:2.44
Shares:971.04K
Float Shares:954.67K
Volume Ratio:0.03
T/O Rate:19.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-46.5038
EPS(LYR):-48.7200
ROE:-315.99%
ROA:-157.81%
PB:1.48
PE(LYR):-0.10

Loading ...

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Jun 24

Autonomix Medical Announces Standalone Neural Sensing Program With Evidence of Real-Time Renal Nerve Activity Change

THOMSON REUTERS
·
Jun 22

Autonomix Medical announces standalone neural sensing platform after preclinical renal nerve activity results

Reuters
·
Jun 22

Autonomix Medical Announces Standalone Neural Sensing Program with Evidence of Real-Time Renal Nerve Activity Change

GlobeNewswire
·
Jun 22

Autonomix announces reverse stock split

TIPRANKS
·
Jun 19

Autonomix Medical effects 1-for-21 reverse stock split June 24

Reuters
·
Jun 19

Autonomix Announces Reverse Stock Split

THOMSON REUTERS
·
Jun 19

Autonomix CEO Hauser touts growing conference recognition for nerve-sensing platform in CEO Corner interview

Reuters
·
Jun 10

Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology

THOMSON REUTERS
·
Jun 10

Autonomix Medical spotlights pancreatic cancer pain feasibility data at surgical oncology meeting

Reuters
·
Jun 04

Autonomix Medical joins virtual investor “What This Means” segment on SSO annual meeting data

Reuters
·
Jun 04

Autonomix Medical Highlights Clinical Data Presented at Society of Surgical Oncology Annual Meeting in Virtual Investor "What This Means" Segment Featuring City of Hope Chief of Medicine

GlobeNewswire
·
Jun 04

Analysts Offer Insights on Healthcare Companies: Bioline RX Ltd Sponsored ADR (BLRX), BeOne Medicines (ONC) and Autonomix Medical, Inc. (AMIX)

TIPRANKS
·
Jun 02

Autonomix net loss widens to $16.7 million in FY26; operating expenses rise 47% to $17.03 million

Reuters
·
May 28

Autonomix granted U.S. patent for transvascular monitoring, treatment systems

TIPRANKS
·
May 19

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems With Real-Time Procedural Validation

THOMSON REUTERS
·
May 19

Autonomix Medical wins US patent for transvascular monitoring, real-time procedural validation system

Reuters
·
May 19

Autonomix Medical, Inc. Granted U.S. Patent for Transvascular Monitoring and Treatment Systems with Real-Time Procedural Validation

GlobeNewswire
·
May 19

Autonomix Medical attends EuroPCR with abstracts on pancreatic cancer pain mitigation

Reuters
·
May 18

Autonomix Medical Announces Abstract Acceptances at Europcr 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation

THOMSON REUTERS
·
May 18